Premium
VioQuest Pharmaceuticals Inc (CE) (VOQP)
USOTC
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
VioQuest Pharmaceuticals (OTCBB: VOQP) today provided a strategic alternatives review and operations update. As disclosed in the Company?s periodic filings with the SEC...
VioQuest Pharmaceuticals (OTCBB: VOQP) today announced that the United States Patent and Trademark Office has issued the first patent for the company?s investigational product...
BOSTON, Aug. 25 /PRNewswire/ -- Scimitar Equity, LLC issues a review of VioQuest Pharmaceuticals, Inc (OTC:VOQP) (BULLETIN BOARD: VOQP) , entitled, "Creating Value; Turnaround Leverages Product...
VioQuest Pharmaceuticals, Inc. (OTCBB: VOQP) today reported its financial results for the three- and six-month periods ended June 30, 2008, and provided an update on recent...
VioQuest Pharmaceuticals (OTCBB: VOQP) announced today that the company?s novel Akt inhibitor VQD-002 (triciribine phosphate monohydrate, or TCN-P) has been selected as one of...
BOSTON, July 29 /PRNewswire/ -- Scimitar Equity, LLC issues a review of VioQuest Pharmaceuticals, Inc (OTC:VOQP) (BULLETIN BOARD: VOQP) , entitled, "510k Application Submitted for Xyfid(TM) and...
VioQuest Pharmaceuticals (OTCBB: VOQP) announced that Christopher P. Schnittker, CPA, has joined the company as vice president and chief financial officer (CFO) effective today...
VioQuest Pharmaceuticals (OTCBB: VOQP) today announced the submission of a 510(k) application to the United States Food and Drug Administration (FDA). The application seeks...
VioQuest Pharmaceuticals (OTCBB: VOQP) today reported updated data from a Phase 1 dose escalation study evaluating Lenocta? (sodium stibogluconate) in combination with...
VioQuest Pharmaceuticals (OTCBB: VOQP) today reported its financial results for the first quarter ended March 31, 2008. For the first quarter of 2008, operating expenses...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 0 | 0 | CS |
| 52 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 0 | 0 | CS |
| 156 | -0.002999 | -99.9666666667 | 0.003 | 0.003 | 1.0E-6 | 10 | 1.0E-6 | CS |
| 260 | -0.003599 | -99.9722222222 | 0.0036 | 0.02 | 1.0E-6 | 13151 | 0.00648724 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0,004 (5,26%) | 147,81M |
| AURIAuri Inc New (PK) | US$ 0,0002 (-20,00%) | 76,04M |
| GTCHGBT Technologies Inc (PK) | US$ 0,0001 (-50,00%) | 35,56M |
| GRLFGreen Leaf Innovations Inc (PK) | US$ 0,0001 (0,00%) | 35,36M |
| CBGLCannabis Global Inc (PK) | US$ 0,0001 (0,00%) | 28,08M |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
